SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,065 | +11.6% | 173,772 | +5.4% | 0.03% | +25.0% |
| Q2 2023 | $18,877 | +57.9% | 164,840 | +90.1% | 0.02% | +50.0% |
| Q1 2023 | $11,954 | +1.2% | 86,733 | -4.9% | 0.02% | 0.0% |
| Q4 2022 | $11,818 | -99.9% | 91,200 | +1.1% | 0.02% | +14.3% |
| Q3 2022 | $9,971,000 | +43.2% | 90,200 | -2.9% | 0.01% | +55.6% |
| Q2 2022 | $6,965,000 | -6.8% | 92,915 | -2.9% | 0.01% | +12.5% |
| Q1 2022 | $7,476,000 | -15.5% | 95,700 | -2.5% | 0.01% | -11.1% |
| Q4 2021 | $8,843,000 | +8.3% | 98,200 | +11.2% | 0.01% | 0.0% |
| Q3 2021 | $8,166,000 | +23.1% | 88,300 | +3.5% | 0.01% | +28.6% |
| Q2 2021 | $6,631,000 | +0.8% | 85,300 | -3.4% | 0.01% | 0.0% |
| Q1 2021 | $6,581,000 | -62.7% | 88,300 | -14.6% | 0.01% | -65.0% |
| Q4 2020 | $17,623,000 | +12.7% | 103,368 | -7.2% | 0.02% | +5.3% |
| Q3 2020 | $15,637,000 | -24.6% | 111,352 | -14.0% | 0.02% | -26.9% |
| Q2 2020 | $20,751,000 | +61.5% | 129,417 | -1.5% | 0.03% | +36.8% |
| Q1 2020 | $12,847,000 | -23.4% | 131,332 | +1.1% | 0.02% | -5.0% |
| Q4 2019 | $16,769,000 | +69.6% | 129,952 | -1.0% | 0.02% | +53.8% |
| Q3 2019 | $9,885,000 | -51.6% | 131,243 | -2.4% | 0.01% | -50.0% |
| Q2 2019 | $20,429,000 | +30.2% | 134,443 | +2.2% | 0.03% | +30.0% |
| Q1 2019 | $15,685,000 | +7.8% | 131,593 | -1.3% | 0.02% | -4.8% |
| Q4 2018 | $14,549,000 | -30.8% | 133,315 | +2.4% | 0.02% | -16.0% |
| Q3 2018 | $21,023,000 | +22.8% | 130,165 | +0.5% | 0.02% | +19.0% |
| Q2 2018 | $17,126,000 | +218.5% | 129,566 | +78.5% | 0.02% | +200.0% |
| Q1 2018 | $5,377,000 | +46.4% | 72,570 | +10.0% | 0.01% | +75.0% |
| Q4 2017 | $3,672,000 | +27.9% | 66,000 | +4.3% | 0.00% | 0.0% |
| Q3 2017 | $2,871,000 | +53.4% | 63,300 | +14.1% | 0.00% | +100.0% |
| Q2 2017 | $1,871,000 | +19.5% | 55,500 | +4.9% | 0.00% | 0.0% |
| Q1 2017 | $1,566,000 | +7.9% | 52,901 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,451,000 | -49.8% | 52,900 | +12.4% | 0.00% | -50.0% |
| Q3 2016 | $2,890,000 | +239.2% | 47,059 | +5.3% | 0.00% | +300.0% |
| Q2 2016 | $852,000 | -2.4% | 44,700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $873,000 | -49.4% | 44,700 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $1,725,000 | +36.4% | 44,700 | +13.5% | 0.00% | +50.0% |
| Q3 2015 | $1,265,000 | -4.4% | 39,400 | -9.4% | 0.00% | 0.0% |
| Q2 2015 | $1,323,000 | -55.2% | 43,473 | -30.4% | 0.00% | -60.0% |
| Q3 2013 | $2,952,000 | – | 62,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |